PUBLISHER: The Insight Partners | PRODUCT CODE: 1562362
PUBLISHER: The Insight Partners | PRODUCT CODE: 1562362
South & Central America Sarcopenia Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type and Distribution Channel
The South & Central America sarcopenia treatment market was valued at US$ 189.59 million in 2022 and is expected to reach US$ 268.50 million by 2030; it is estimated to register a CAGR of 4.4% from 2022 to 2030 .
Products in Clinical Trial Phases Fuel South & Central America Sarcopenia Treatment Market
A few major players operating in the sarcopenia treatment market are increasingly focusing on drug development to treat sarcopenia. Novel sarcopenia treatments are currently being developed and tested in clinical trials. A few of these products are mentioned below:
Sarcopenia Drug Under Clinical Development
Company Name
Interventions
Conditions
Clinical Trial Stage
Abbott Nutrition
Medical Food with AN777
Oral Nutritional Formula
Malnutrition
Sarcopenia
PHASE3
Nutricia Research
Dietary Supplement: Bolus ONS A
Dietary Supplement: Bolus ONS B
Dietary Supplement: Bolus ONS C
Dietary Supplement: Bolus ONS D
Sarcopenia
PHASE1
Novartis Pharmaceuticals
Drug: Bimagrumab
Sarcopenia
PHASE2
McMaster University
Behavioural: Step Reduction
Sarcopenia
PHASE1
Metabolic Technologies Inc.
Dietary Supplement: Placebo
Drug: HMB Plus Vitamin D
Behavioural: Non-Exercise
Behavioural: Exercise
Sarcopenia
PHASE1
Merck Sharp & Dohme LLC
Drug: Comparator MK-077
Drug: Comparator Placebo
Sarcopenia
PHASE2
Immunotec Inc.
Dietary Supplement: Immunocal
Dietary Supplement: Casein
Aging and Sarcopenia
PHASE2
Lijun Yang
Combination Product: 3-Month Intensive Intervention
Sarcopenia
PHASE4
Regeneron Pharmaceuticals
Drug: REGN1033 (SAR391786)
Drug: Placebo
Sarcopenia
PHASE2
Source: Company Websites and The Insight Partners Analysis
Therefore, the extending pipeline of drugs that are in different stages of clinical development presents significant opportunities for the sarcopenia treatment market growth.
South & Central America Sarcopenia Treatment Market Overview
The sarcopenia treatment market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. A rise in the geriatric population and the surging incidence of vitamin Deficiency fuels the sarcopenia treatment market in South & Central America.
The introduction of new regulations by the National Sanitary Surveillance Agency (ANVISA) for dietary supplements in 2018 made the entry of new brands easier in Brazil. Moreover, it helped existing brands to flourish and innovate in the country. According to a study published in the National Library of Medicine, the elderly population is rapidly growing in Brazil, resulting in an increased prevalence of chronic conditions associated with old age. The overall prevalence of sarcopenia in the elderly population in Brazil was ~20.0% in 2020. According to an article published by National Institute of Health, in 2022, the prevalence of probable sarcopenia is 42.0% in older Brazilian women.
South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Sarcopenia Treatment Market Segmentation
The South & Central America sarcopenia treatment market is categorized into treatment type, distribution channel, and country.
Based on treatment type, the South & Central America sarcopenia treatment market is segmented into vitamin D and calcium supplement, protein supplement, vitamin B12 supplement, and others. The vitamin D and calcium supplement segment held the largest South & Central America sarcopenia treatment market share in 2022.
In terms of distribution channel, the South & Central America sarcopenia treatment market is segmented into pharmacies, retail channels, online channels, and others. The pharmacies segment held the largest South & Central America sarcopenia treatment market share in 2022.
By country, the South & Central America sarcopenia treatment market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America sarcopenia treatment market share in 2022.
Abbott Laboratories, Bayer AG, Nestle Health Science SA, Novartis AG, Pfizer Inc, Sanofi SA, Amway Corp, and GSK Plc are some of the leading companies operating in the South & Central America sarcopenia treatment market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. South & Central America Sarcopenia Treatment Market - Key Industry Dynamics
- 4.1 South & Central America Sarcopenia Treatment Market - Key Industry Dynamics
- 4.2 Market Drivers
- 4.2.1 Upsurge in Geriatric Population
- 4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
- 4.3 Key Market Restraints:
- 4.3.1 Unavailability of Direct Interventions
- 4.4 Key Market Opportunities:
- 4.4.1 Products in Clinical Trial Phases
- 4.5 Future Trends:
- 4.5.1 Rising Awareness About Sarcopenia
- 4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - South & Central America Market Analysis
- 5.1 South & Central America Sarcopenia Treatment Market Revenue (US$ Million), 2020- 2030
- 5.2 South & Central America Sarcopenia Treatment Market Forecast and Analysis
6. South & Central America Sarcopenia Treatment Market Analysis - By Treatment Type
- 6.1 Vitamin D and Calcium Supplement
- 6.1.1 Overview
- 6.1.2 Vitamin D and Calcium Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
- 6.2 Protein Supplement
- 6.2.1 Overview
- 6.2.2 Protein Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
- 6.3 Vitamin B12 Supplement
- 6.3.1 Overview
- 6.3.2 Vitamin B12 Supplement: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
- 6.4 Others
- 6.4.1 Overview
- 6.4.2 Others: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Sarcopenia Treatment Market Analysis - By Distribution Channel
- 7.1 Pharmacies
- 7.1.1 Overview
- 7.1.2 Pharmacies: South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
- 7.2 Retail Channels
- 7.2.1 Overview
- 7.2.2 Retail Channels: South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
- 7.3 Online Channels
- 7.3.1 Overview
- 7.3.2 Online Channels : South & Central America Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
- 7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Sarcopenia Treatment Market - Country Analysis
- 8.1 South & Central America
- 8.1.1 South & Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
- 8.1.1.1 South & Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
- 8.1.1.2 Brazil Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
- 8.1.1.2.1 Brazil Sarcopenia Treatment Market Breakdown by Treatment Type
- 8.1.1.2.2 Brazil Sarcopenia Treatment Market Breakdown by Distribution Channel
- 8.1.1.3 Argentina Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
- 8.1.1.3.1 Argentina Sarcopenia Treatment Market Breakdown by Treatment Type
- 8.1.1.3.2 Argentina Sarcopenia Treatment Market Breakdown by Distribution Channel
- 8.1.1.4 Rest of South & Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
- 8.1.1.4.1 Rest of South & Central America Sarcopenia Treatment Market Breakdown by Treatment Type
- 8.1.1.4.2 Rest of South & Central America Sarcopenia Treatment Market Breakdown by Distribution Channel
- 8.1.1 South & Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
9. Sarcopenia Treatment Market-Industry Landscape
- 9.1 Overview
- 9.2 Growth Strategies in the Sarcopenia Treatment Market
- 9.3 Inorganic Growth Strategies
- 9.3.1 Overview
- 9.4 Organic Growth Strategies
- 9.4.1 Overview
10. Company Profiles
- 10.1 Abbott Laboratories
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
- 10.2 Bayer AG
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
- 10.3 Nestle Health Science SA
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
- 10.4 Novartis AG
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
- 10.5 Pfizer Inc
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
- 10.6 Sanofi SA
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
- 10.7 Amway Corp
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
- 10.8 GSK Plc
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
11. Appendix
- 11.1 About The Insight Partners
- 11.2 Glossary of Terms
List Of Tables
- Table 1. South & Central America Sarcopenia Treatment Market Segmentation
- Table 2. Sarcopenia Drug Under Clinical Development
- Table 3. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
- Table 4. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
- Table 5. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
- Table 6. South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
- Table 7. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
- Table 8. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
- Table 9. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
- Table 10. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
- Table 11. Rest of South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
- Table 12. Rest of South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
- Table 13. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
- Table 14. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
- Table 15. Glossary of Terms, Sarcopenia Treatment Market
List Of Figures
- Figure 1. South & Central America Sarcopenia Treatment Market Segmentation, By Country
- Figure 2. Impact Analysis of Drivers and Restraints
- Figure 3. South & Central America Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
- Figure 4. South & Central America Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
- Figure 5. Vitamin D and Calcium Supplement: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
- Figure 6. Protein Supplement: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
- Figure 7. Vitamin B12 Supplement: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
- Figure 8. Others: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
- Figure 9. South & Central America Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
- Figure 10. Pharmacies: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
- Figure 11. Retail Channels: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
- Figure 12. Online Channels : South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
- Figure 13. Others: South & Central America Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
- Figure 14. South & Central America Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
- Figure 15. South & Central America Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
- Figure 16. Brazil Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
- Figure 17. Argentina Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
- Figure 18. Rest of South & Central America Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
- Figure 19. Growth Strategies in the Sarcopenia Treatment Market
